Abstract
In addition to the well-known use of microbubbles (MBs) as powerful contrast agents for general tissue delineation and perfusion in ultrasound (US) imaging, US-targeted MB destruction (UTMD) has been demonstrated to be an emerging technique for noninvasive drug delivery to tumor sites. However, the very limited drug-loading capacity of conventional MBs remains a great obstacle to their application as an efficacious cancer therapy. In this study, an amphiphilic Janus camptothecin-floxuridine (CF) conjugate was synthesized to engineer CF MBs with ultrahigh drug-loading contents (up to 56.7 ± 2.3%). CF MBs were proven to be an excellent contrast agent to enhance US imaging for identifying the location and size of tumors. Upon local US exposure to burst CF MBs under the guidance of contrast-enhanced US imaging, successful conversion of CF MBs into CF NPs in situ resulted in ~14 times higher drug accumulation of the CF conjugate via the sonoporation effect than that of CF NPs and CF MBs without US. After CF was internalized by tumor cells and its ester bond was hydrolyzed, camptothecin (CPT) and floxuridine (FUDR) were released at an exact 1:1 ratio to achieve coordinated pharmacokinetics, leading to significantly higher tumor growth inhibition in murine tumor models of CF MBs combined with US (~72.4%) than CF NPs (~54.1%) and liposomes loaded with CPT and FUDR (~21.6%). Overall, these results demonstrate that the combination of CF MBs with US is a powerful strategy for remarkably enhancing the combined chemotherapeutic efficacy and greatly reducing the undesirable side effects.
Highlights
Nanotherapy has attracted extensive interest for cancer treatments, mostly because of the uniquely appealing features of nanomedicines, for example, improved circulation, passive accumulation in tumors via the enhanced permeability and retention (EPR) effect of nanoparticles, and reduced toxicity[1,2,3,4]
By using the UStargeted MB destruction (UTMD) technique, camptothecin-floxuridine MBs (CF MBs) with high drug-loading contents were converted into CF NPs and effectively accumulated in tumors due to the enhanced vasculature permeation and cellular uptake enabled by the sonoporation effect, circumventing the limitations of the EPR effect
In summary, we successfully engineered CF MBs with ultrahigh loading contents of two synergetic drugs and an excellent capability to enhance US imaging for identifying the location and size of tumors
Summary
Nanotherapy has attracted extensive interest for cancer treatments, mostly because of the uniquely appealing features of nanomedicines, for example, improved circulation, passive accumulation in tumors via the enhanced permeability and retention (EPR) effect of nanoparticles, and reduced toxicity[1,2,3,4]. CF MBs + US can greatly improve drug delivery efficiency and therapeutic cytotoxicity, which is consistent with the results of the cellular uptake experiments (Fig. 3a−c).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
